MORGAN STANLEY - 31 Dec 2025 SCHEDULE 13G/A Report for C4 Therapeutics, Inc. Common Stock (CCCC)

Filing Manager: MORGAN STANLEY
Reporting Manager: Morgan Stanley
Security: C4 Therapeutics, Inc. Common Stock
Symbol: CCCC
Shares outstanding: 96,496,677 shares
Disclosed Ownership: 8,974,191 shares
Ownership: 9.3%
Form type: SCHEDULE 13G/A
Filing time: 11 Feb 2026, 12:58:54 UTC
Date of event: 31 Dec 2025
Previous filing: 07 Aug 2025
SEC: View on sec.gov

Reporting Managers (2)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
Morgan Stanley	9.3%	8,974,191	0	8,973,891	Chris O'Hara	Authorized Signatory, Morgan Stanley
Morgan Stanley & Co. LLC	9.2%	8,897,942	0	8,897,942	Chris O'Hara	Authorized Signatory, Morgan Stanley & Co. LLC